September 28, 2016 |
|
---|---|
7:30 AM | Registration – Lobby |
7:45 AM | Breakfast – The Pechet Room |
8:45 AM | Welcome Remarks – Amphitheatre |
9:00 AM – 10:20 AM |
WHY ASIA? – Understanding the opportunities for partnering and financing in the Asian markets including the epidemiology of Asia
|
10:20 AM – 10:35 AM | Break |
10:35 AM – 11:25 AM |
BUILDING YOUR ASIAN IQ – The key issues to understand and the steps to take in Asia
|
11:30 AM – 12:25 PM |
FOCUS ON SIMILARITIES AND DIFFERENCES – Parsing the myths, true and untrue, about China, Korea and Japan
|
12:30 PM – 1:40 PM | Lunch with the Experts |
1:45 PM – 2:40 PM |
MONEY IN ASIA – Investing in biotech companies in Asia and North America
|
2:40 PM – 2:55 PM | Break |
2:55 PM – 3:40 PM |
CLINICAL TRIAL DESIGN IN ASIA – Collaborating with CROs and CMOs on where you run your study and where you manufacture
|
3:45 PM – 4:55 PM |
THE DEAL LANDSCAPE – An inside look at the cross-border deals including successful deals, unsuccessful deals and breakthrough deals
|
5:00 PM – 6:30 PM | Networking Reception |
September 29, 2016 |
|
---|---|
7:45 AM | Breakfast – The Pechet Room |
8:45 AM – 9:55 AM |
GLOBALIZATION OF THE ASIAN INDUSTRY – How North American biopharma companies can attract Asian innovation through outward and/or inward partnerships and investments
|
9:55 AM – 10:10 AM | Break |
10:10 AM – 11:05 AM |
DUE DILIGENCE AND DEAL MAKING IN ASIA – What you need to know to avoid pitfalls and ensure an effective deal
|
11:10 AM – 12:05 PM |
THE COMPLEXITIES OF REGULATORY REGIMES – Understanding and navigating the various regulatory regimes in Asia
|
12:10 PM– 1:20 PM | Lunch with the Experts |
1:25 PM – 2:20 PM |
MANAGING INTELLECTUAL PROPERTY IN ASIA – The challenges and opportunities for biotech companies, including retaining US commercialization rights in license deals
|
2:25 PM – 3:30 PM |
THE VIEW FROM BIG PHARMA – How does Big Pharma view the role of Trans-Pacific Partnerships?
|
3:30 PM – 4:30 PM | Closing Reception |